Why did states that spent decades and enormous budgets building biological weapons never use them in a major war? Squeamishness is the easy answer, and it collapses the moment you remember what those same governments did with fire and fission. The better answer starts with the strange spot these weapons occupied: technically promising and militarily awkward at once, and classified from the first culture dish onward. Anthrax grown in a converted plant is only a weapon once someone decides how, where, and against whom it gets released, and that decision kept sliding onto next year's desk. The deferral is worth understanding in 2026, while Washington rewrites the rules for gene synthesis, sequence screening, and foreign money in the life sciences. National security language now governs work that used to sit quietly under public health. What held the last century back has become a working question about the next one.
Coverage of that policy turn is amnesiac. You get the mechanics in fine detail, down to the screening thresholds for synthesis orders and which grants now draw a second look. The record goes missing. Governments have already run large biological weapons programs, staffed by scientists with reputations and pensions, and those programs left a documented history of concealment on an industrial scale, plus the misjudgments the concealment protected. Skip that history and the present feels unprecedented, which flatters everyone currently drafting rules and helps nobody judge whether the rules will work. It also buries a pattern that keeps returning: secrecy adopted for sound reasons, then quietly extended until nobody outside the program could check its claims. Jeanne Guillemin's Biological Weapons fills that hole, uncomfortably.
Guillemin builds her story from archival material, tracking how scientists, soldiers, and statesmen assembled state-sponsored programs from early experiments through the Second World War and into the decades after. Her cast does most of the argumentative work. These programs ran on biologists who thought of themselves as public health people, working beside officers with only a rough sense of what they were requisitioning. Officials then approved capabilities they could not describe in public. Institutional momentum handled the rest. The puzzle she keeps circling is nonuse. Weapons designed explicitly to kill civilians sat in inventory through conflicts that spared very little else.
Guillemin treats that outcome as a historical product with identifiable causes, and the cause she documents most convincingly is military skepticism. Commanders disliked a weapon whose effects nobody could forecast, least of all downwind of their own positions. Legal prohibitions and professional norms mattered too, reinforced by the plain difficulty of releasing a pathogen without contaminating your own operation. Secrecy runs through every stage and draws her sharpest writing. Classification shaped what got built and what officials believed about programs they could not see. It also produced a durable feedback problem: a program invisible to outside assessment tends to generate the threat estimates that justify its own expansion, and nobody with standing is available to say otherwise.
From there she turns to the live questions, beginning with deterrence and what actually stops a state from using what it has stockpiled. Constraining proliferation follows, along with the duties owed by the scientists who create these capabilities and the officials who supervise them. Her answer throughout is that clear public understanding beats dread amplified by official silence as a route to sound policy and lower risk. I am not convinced. That claim requires a public willing to absorb technical detail and agencies willing to declassify enough to supply it, and the history she assembles is largely a record of neither condition holding for long.
Transparency also carries costs she handles lightly, since some published methods are worth considerably more to a hostile actor than to an informed citizen. The second strain is scale. The restraints Guillemin identifies belong to states with buildings that can be inspected and reputations that can be lost. Whether anything comparable operates where synthesis is cheap and distributed is an open question, and a history of state programs cannot settle it. Taken as an account of mechanism, though, the book holds up well.
So the opening puzzle turns out to be the practical one. Weapons that were built and never used were held back by arrangements people made and can unmake, some written into treaty language, some carried around in professional habit. Guillemin's reconstruction of how those arrangements were assembled is worth a few evenings if you want something sturdier than headline anxiety about the life sciences. It leaves you with one question sharp enough to put to whoever is drafting the next set of rules: who, outside this room, is able to tell you that you are wrong?